Modeling madness in mice: One piece at a time

被引:233
作者
Arguello, P. Alexander
Gogos, Joseph A.
机构
[1] Columbia Univ, Med Ctr, Ctr Neurobiol & Behav, New York, NY 10032 USA
[2] Columbia Univ, Med Ctr, Dept Physiol & Cellular Biophys, New York, NY 10032 USA
关键词
D O I
10.1016/j.neuron.2006.09.023
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Mouse models that recapitulate the full phenotypic spectrum of a psychiatric disorder, such as schizophrenia, are impossible. However, a more piecemeal recreation of phenotypic components is feasible and promises to harness the power of animal models using approaches that are either off limits or confounded by drug treatment in humans. In that context, animal models will have a central and indispensable role in the process of discovering the causes of psychiatric disorders and generating novel, mechanism-based treatments. Here, we discuss current approaches used to generate animal models of psychiatric disorders, address the different components of these disorders that can be modeled in animals, and describe currently available analytical tools. We also discuss accumulating empirical data and take an in-depth look at what we believe to be the future of animal models made possible by recent advances in psychiatric genetics.
引用
收藏
页码:179 / 196
页数:18
相关论文
共 168 条
[81]   Episodic memory in nonhumans: what, and where, is when? [J].
Hampton, RR ;
Schwartz, BL .
CURRENT OPINION IN NEUROBIOLOGY, 2004, 14 (02) :192-197
[82]   Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia [J].
Hashimoto, R ;
Straub, RE ;
Weickert, CS ;
Hyde, TM ;
Kleinman, JE ;
Weinberger, DR .
MOLECULAR PSYCHIATRY, 2004, 9 (03) :299-307
[83]   Haplotype transmission analysis provides evidence of association for DISC1 to schizophrenia and suggests sex-dependent effects [J].
Hennah, W ;
Varilo, T ;
Kestilä, M ;
Paunio, T ;
Arajärvi, R ;
Haukka, J ;
Parker, A ;
Martin, R ;
Levitzky, S ;
Partonen, T ;
Meyer, J ;
Lönnqvist, J ;
Peltonen, L ;
Ekelund, J .
HUMAN MOLECULAR GENETICS, 2003, 12 (23) :3151-3159
[84]   Brain catecholamine metabolism in catechol-O-methyltransferase (COMT)-deficient mice [J].
Huotari, M ;
Gogos, JA ;
Karayiorgou, M ;
Koponen, I ;
Forsberg, M ;
Raasmaja, A ;
Hyttinen, J ;
Männistö, PT .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2002, 15 (02) :246-256
[85]   d-amphetamine responses in catechol-O-methyltransferase (COMT) disrupted mice [J].
Huotari, M ;
García-Horsman, JA ;
Karayiorgou, M ;
Gogos, JA ;
Männistö, PT .
PSYCHOPHARMACOLOGY, 2004, 172 (01) :1-10
[86]  
Jablensky A., 2003, SCHIZOPHRENIA, P203
[87]   Hyperprolinemia is a risk factor for schizoaffective disorder [J].
Jacquet, H ;
Demily, C ;
Houy, E ;
Hecketsweiler, B ;
Bou, J ;
Raux, G ;
Lerond, J ;
Allio, G ;
Haouzir, S ;
Tillaux, A ;
Bellegou, C ;
Fouldrin, G ;
Delamillieure, P ;
Ménard, JF ;
Dollfus, S ;
D'Amato, T ;
Petit, M ;
Thibaut, F ;
Frébourg, T ;
Campion, D .
MOLECULAR PSYCHIATRY, 2005, 10 (05) :479-485
[88]  
JAVITT DC, 1991, AM J PSYCHIAT, V148, P1301
[89]   Deficits in auditory and visual context-dependent processing in schizophrenia -: Defining the pattern [J].
Javitt, DC ;
Shelley, AM ;
Silipo, G ;
Lieberman, JA .
ARCHIVES OF GENERAL PSYCHIATRY, 2000, 57 (12) :1131-1137
[90]   Pre-clinical models of cognitive dysfunction in schizophrenia: new avenues to addressing unmet needs [J].
Jentsch, JD .
CLINICAL NEUROSCIENCE RESEARCH, 2003, 3 (4-5) :303-313